NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment. - Haviland JA; Reiland H; Butz DE; Tonelli M; Porter WP; Zucchi R; Scanlan TS; Chiellini G; Assadi-Porter FM (Obesity (Silver Spring, Md.), 2013)